GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Digicann Ventures Inc (XCNQ:DCNN) » Definitions » YoY EBITDA Growth

Digicann Ventures (XCNQ:DCNN) YoY EBITDA Growth : -98.47% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Digicann Ventures YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Digicann Ventures's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -98.47%.

Digicann Ventures's EBITDA per Share for the three months ended in Mar. 2024 was C$0.00.


Digicann Ventures YoY EBITDA Growth Historical Data

The historical data trend for Digicann Ventures's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Digicann Ventures YoY EBITDA Growth Chart

Digicann Ventures Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -712.29 52.54 106.59 -143.59 115.45

Digicann Ventures Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -98.12 146.62 318.39 113.26 -98.47

Digicann Ventures YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Digicann Ventures's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(1.226--7.937)/ | -7.937 |
=115.45 %

Digicann Ventures's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(0.002-0.131)/ | 0.131 |
=-98.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Digicann Ventures YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Digicann Ventures's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Digicann Ventures (XCNQ:DCNN) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C1H2
Digicann Ventures Inc Formerly Agra Ventures Ltd is a pharmaceutical company engaged in the sale of cannabis-related products. The company's geographic segment includes Germany and Canada, with the majority of sales coming from Germany.
Executives
Nicholas Jonathan Kuzyk Director, Senior Officer

Digicann Ventures (XCNQ:DCNN) Headlines

No Headlines